David Rescott
Stock Analyst at Baird
(3.14)
# 1,162
Out of 4,944 analysts
67
Total ratings
45.45%
Success rate
2.41%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Rescott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PEN Penumbra | Maintains: Buy | $300 → $310 | $248.55 | +24.72% | 31 | Jul 30, 2025 | |
| EW Edwards Lifesciences | Maintains: Neutral | $78 → $79 | $76.93 | +2.69% | 5 | Jul 25, 2025 | |
| BSX Boston Scientific | Maintains: Outperform | $117 → $123 | $102.64 | +19.84% | 8 | Jul 24, 2025 | |
| HAE Haemonetics | Initiates: Outperform | $87 | $52.23 | +66.57% | 1 | Jun 26, 2025 | |
| MDT Medtronic | Maintains: Neutral | $94 → $92 | $92.08 | -0.09% | 6 | May 22, 2025 | |
| LIVN LivaNova | Maintains: Outperform | $55 → $61 | $50.64 | +20.46% | 4 | May 8, 2025 | |
| MMSI Merit Medical Systems | Maintains: Outperform | $111 → $110 | $84.76 | +29.78% | 3 | Apr 25, 2025 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $600 → $575 | $478.19 | +20.25% | 3 | Apr 23, 2025 | |
| SIBN SI-BONE | Maintains: Buy | $25 → $26 | $15.22 | +70.83% | 6 | Dec 22, 2023 |
Penumbra
Jul 30, 2025
Maintains: Buy
Price Target: $300 → $310
Current: $248.55
Upside: +24.72%
Edwards Lifesciences
Jul 25, 2025
Maintains: Neutral
Price Target: $78 → $79
Current: $76.93
Upside: +2.69%
Boston Scientific
Jul 24, 2025
Maintains: Outperform
Price Target: $117 → $123
Current: $102.64
Upside: +19.84%
Haemonetics
Jun 26, 2025
Initiates: Outperform
Price Target: $87
Current: $52.23
Upside: +66.57%
Medtronic
May 22, 2025
Maintains: Neutral
Price Target: $94 → $92
Current: $92.08
Upside: -0.09%
LivaNova
May 8, 2025
Maintains: Outperform
Price Target: $55 → $61
Current: $50.64
Upside: +20.46%
Merit Medical Systems
Apr 25, 2025
Maintains: Outperform
Price Target: $111 → $110
Current: $84.76
Upside: +29.78%
Intuitive Surgical
Apr 23, 2025
Maintains: Outperform
Price Target: $600 → $575
Current: $478.19
Upside: +20.25%
SI-BONE
Dec 22, 2023
Maintains: Buy
Price Target: $25 → $26
Current: $15.22
Upside: +70.83%